SCHEMBL4308994

SCHEMBL4308994

Cc1ccsc1C(=O)Nc1cc(CNCCN2CCOCC2)ccc1C=Cc1n[nH]c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 4/20 0.60
▸ AURKB Q96GD4 4/20 0.60
▸ PARP1 P09874 1/20 0.40
▸ PDGFRB P09619 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ MAPK10 P53779 2/20 0.36
▸ MAPK8 P45983 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ BCL3 P20749 1/20 0.36
▸ PDCD1 Q15116 1/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4308985 1.00 AURKA (0.60) AURKAAURKBPARP1PDGFRBKDR
SCHEMBL14989352 0.92 AURKB (0.70) AURKAAURKBGFER
SCHEMBL14989354 0.92 AURKB (0.70) AURKAAURKBGFER
SCHEMBL14989031 0.90 AURKB (0.72) AURKAAURKB
SCHEMBL14989033 0.90 AURKB (0.72) AURKAAURKB
Hydrochloric Acid SCHEMBL4314035 0.89 AURKB (0.71) AURKAAURKB
Hydrochloric Acid SCHEMBL4314042 0.89 AURKB (0.71) AURKAAURKB
SCHEMBL14989121 0.89 AURKA (0.48) AURKAAURKBPARP1PDGFRBKDR
SCHEMBL4308959 0.88 AURKA (0.56) AURKAAURKBPARP1KDRALDH1A1
SCHEMBL4308962 0.88 AURKA (0.56) AURKAAURKBPARP1KDRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1847532-B1 IGF-1R INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2013-06-05 — — EP claimed
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US claimed
EP-1847532-B1 IGF-1R INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2013-06-05 — — EP disclosed
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 AURKA 3687/4885AURKB 3438/4885PARP1 3697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback